| 04.05.2011 - Shanghai Pharma share sale to raise $2.2 bln as Temasek, Pfizer invest |
| Shanghai Pharmaceuticals Holding Co., China’s second-largest drug distributor, will sell new shares to Temasek Holdings Pte and Pfizer Inc. (PFE) in an offering in Hong Kong of as much as $2.2 billion of stock to fund acquisitions. Temasek, a Singapore state investment company, Pfizer, Guoco Group and Bank of China Group Investment will buy a total of $550 million shares for HK$21.80 to HK$26 apiece..............................................Full Article: Source |